Schedule 13G ownership disclosure

Vera Therapeutics Inc

Common Stock · CUSIP: 92337R101

Event date: 2025-06-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deerfield Mgmt, L.P.

    Shares: 3,348,117.00 · Class: 5.25%

  • Deerfield Management Company, L.P.

    Shares: 3,348,117.00 · Class: 5.25%

  • Deerfield Partners, L.P.

    Shares: 3,348,117.00 · Class: 5.25%

  • James E. Flynn

    Shares: 3,348,117.00 · Class: 5.25%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-25-000870
Form type
SCHEDULE 13G
Filer
Flynn James E
CIK
CIK 1352546
Filed
Jun 11, 2025
Reporting period
Jun 06, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub